Entity family
Named diseases, disorders, syndromes, injuries, and health conditions. Examples include epilepsy, diabetes, stroke.
This disease is selected. Its supporting articles are shown below.
…is a progressive condition that may lead to liver cirrhosis and hepatocellular carcinoma. It is strongly associated with cardiometabolic diseases such a…
…(≥18 years) with MASLD, and at least one metabolic comorbidity (T2DM, obesity, dyslipidemia, metabolic syndrome, or hypertension) we…
…Introduction Metabolic dysfunction-associated steatotic liver disease (MASLD) affects more than a third of the world’s adult population, maki…
…Introduction Chronic hepatitis B (CHB) remains a major cause of inflammatory liver disease worldwide. …
…Introduction Type 2 diabetes mellitus (T2DM) and metabolic dysfunction-associated steatotic liver disease (M…
…with higher MASLD risk than discordantly high LDL-C, even among T2DM patients with optimal LDL-C and TG levels. Moreover, RC is asso…
…acteria in the human gut. D. welbionis abundance was reduced in MASLD across two cohorts and inversely correlated with fibrosis score…
…bolic dysfunction-associated steatotic liver disease (MASLD) to hepatic fibrosis, and a subset of MASLD subjects has T2D. Identification of mole…
…Metabolic dysfunction-associated steatotic liver disease (MASLD) affects approximately one-quarter of the adult population. Whil…
…onist. Phase II data show tirzepatide is effective in resolving steatohepatitis in patients with MASLD with fibrosis at 52 weeks.2 However, no …
…Introduction Metabolic dysfunction-associated steatotic liver disease (MASLD) is a leading cause of morbidity and mortality due to chronic li…
…eprived areas. This trend parallels the increasing incidence of type 2 diabetes mellitus and obesity. While MASLD is influenced by multiple factors, inc…